Perlin Pharmaceuticals Private Limited
About Perlin Pharmaceuticals Private Limited
Data last updated:
Perlin Pharmaceuticals Private Limited is a private limited company based in Hyderabad, Telangana, India. It operates in the manufacturing segment of the chemicals sector. It was incorporated on 29 November 2019 and has been in existence for over 7 years.
The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U24290TG2019PTC137238. Its GSTIN is 36AAKCP9033B1ZH (Telangana).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors including Satya Srinivas Tangella (Managing Director) and Suryaprabha Anasuri.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Flat No – 309 3rd Floor Infocity Pearl Bhagyalaxmi Nagar Sudharshan Nagar, Hyderabad, Telangana, India – 500019.
Company details
Contact details
Perlin Pharmaceuticals Private Limited's registered office is in Hyderabad, Telangana. Its e-mail address is in the company report.
- Email
- Registered AddressFlat No – 309 3rd Floor Infocity Pearl Bhagyalaxmi Nagar Sudharshan Nagar, Hyderabad, Telangana, India – 500019
- IndustryChemicals, Manufacturing, Other Chemical Product
To see the full contact details of Perlin Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Perlin Pharmaceuticals is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
Financials of Perlin Pharmaceuticals Private Limited
FY 2025 filings availableFinancial Statement Summary
| Metrics | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|
| Profit and Loss Statement | |||
| Revenue from Operations | |||
| Other Income | |||
| Total Revenue | |||
| Cost of Materials Consumed | |||
| Employee Benefit Expense | |||
| Finance Costs | |||
| Depreciation and Amortisation | |||
| Other Expenses | |||
| Total Expenses | |||
| EBITDA | |||
| Profit Before Tax | |||
| Tax Expense | |||
| Net Profit (PAT) | |||
| Balance Sheet | |||
| Share Capital | |||
| Reserves and Surplus | |||
| Net Worth (Total Equity) | |||
| Long-term Borrowings | |||
| Short-term Borrowings | |||
| Trade Payables | |||
| Total Liabilities | |||
| Fixed Assets | |||
| Investments | |||
| Inventories | |||
| Trade Receivables | |||
| Cash and Bank Balance | |||
| Total Assets | |||
Financial Ratios
| Metrics | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|
| Profitability | |||
| EBITDA Margin | |||
| Net Profit Margin | |||
| Return on Equity (ROE) | |||
| Return on Capital Employed (ROCE) | |||
| Return on Assets (ROA) | |||
| Liquidity and Debt | |||
| Current Ratio | |||
| Quick Ratio | |||
| Debt-to-Equity Ratio | |||
| Interest Coverage Ratio | |||
| Efficiency and Growth | |||
| Asset Turnover | |||
| Receivable Days | |||
| Payable Days | |||
| Inventory Days | |||
| Revenue Growth | |||
| Net Profit Growth | |||
To see the full financial statements and ratios of Perlin Pharmaceuticals Private Limited, buy the company report.
Board of directors of Perlin Pharmaceuticals Private Limited
Perlin Pharmaceuticals has 4 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Satya Srinivas Tangella Also directs: Lumea Life Sciences Private Limited, Elitecareoath Foundation | Managing Director | 29 Nov 2019 | 6 Years 10 Months | Current |
| Suryaprabha Anasuri | Director | 29 Nov 2019 | 6 Years 10 Months | Current |
| Lalitha Akondi | Director | 29 Nov 2019 | 6 Years 10 Months | Current |
| Girish Bathina | Director | 28 Jun 2021 | 5 Years 3 Months | Current |
Legal cases
No court or tribunal cases involving Perlin Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Perlin Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Perlin Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 36AAKCP9033B1ZH | Telangana | Active | 27 Feb 2020 |
To see the full GST registrations and return filing status of Perlin Pharmaceuticals Private Limited, buy the company report.
Recent activity
Perlin Pharmaceuticals Private Limited has 5 board changes on record since 2019: 4 appointments and 1 cessation. The latest: Girish Bathina was appointed as Director on 28 Jun 2021.
Frequently asked questions
Perlin Pharmaceuticals is an active private limited company based in Hyderabad, Telangana, India. The company works in manufacturing, within the chemicals industry. It was incorporated on 29 November 2019 (7+ years old) and is registered under CIN U24290TG2019PTC137238.
Perlin Pharmaceuticals has 4 current directors:
- Satya Srinivas Tangella - Managing Director
- Suryaprabha Anasuri - Director
- Lalitha Akondi - Director
- Girish Bathina - Director
The latest financial statements of Perlin Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2020 are in the company report.
The GSTIN of Perlin Pharmaceuticals is 36AAKCP9033B1ZH, registered in Telangana.
The CIN (Corporate Identification Number) of Perlin Pharmaceuticals is U24290TG2019PTC137238. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Perlin Pharmaceuticals was incorporated on 29 November 2019, making it 7+ years old. It is registered with the Registrar of Companies, Hyderabad.
Girish Bathina was appointed as Director on 28 Jun 2021. Manikanta Peethani ceased to be Director on 28 Jun 2021. Lalitha Akondi was appointed as Director on 29 Nov 2019. Perlin Pharmaceuticals has 5 board changes on record in total.
The registered office of Perlin Pharmaceuticals is at Flat No – 309 3rd Floor Infocity Pearl Bhagyalaxmi Nagar Sudharshan Nagar, Hyderabad, Telangana, India – 500019.
Perlin Pharmaceuticals operates in the chemicals industry, in the manufacturing segment.
Perlin Pharmaceuticals can be reached at its registered office: Flat No – 309 3rd Floor Infocity Pearl Bhagyalaxmi Nagar Sudharshan Nagar, Hyderabad, Telangana, India – 500019.